Thermo Fisher falls as 2026 profit midpoint trails estimates

Thermo Fisher Scientific

29/01/2026 14:18

** Shares of medical equipment maker Thermo Fisher Scientific TMO.N fall 5% to $577 premarket

** Co expects 2026 adjusted EPS at $24.22–$24.80; midpoint of $24.51 sits below analysts’ avg estimate of $24.61 – data compiled by LSEG

** Co forecasts 2026 revenue of $46.3 bln–$47.2 bln; analysts’ avg estimate is $46.54 bln

** Q4 revenue of $12.22 bln compared with estimate of $11.95 bln

** Exec says Asia Pacific grew low-single-digit in 2025; China declined by mid-single-digit

** Up to previous close, stock had risen 4.1% in the last 12 months

(Reporting by Puyaan Singh and Sahil Pandey)

((Puyaan.Singh@thomsonreuters.com;))